Cite
HARVARD Citation
Biemans, V. et al. (n.d.). P503 Two year experience with vedolizumab in inflammatory bowel disease patients: results of the ICC case series, a nationwide prospective observational cohort study. Journal of Crohn's and colitis. pp. S363-S364. [Online].